MARY ELLEN MAHONEY M.D.
Prescription History 1750352621
Surgery in Eureka, CA

Active since January 30, 2006PECOS EnrolledAccepts Medicare Assignment
636 HARRIS ST STE A, EUREKA, CA 95503(707) 476-0690(707) 476-0692 Get Directions

NPPES record last updated: February 2, 2024. Verified against the NPPES registry weekly; last sync: October 18, 2026.

Medicare Part D Prescription History

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for MARY ELLEN MAHONEY M.D., an active Surgery specialist practicing in Eureka, CA. Our medical registry currently tracks 2 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 63 documented patient claims. Among these therapy options, the most frequently utilized medication is Letrozole, which accounts for 35 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.

2
Medications
63
Total Claims
171
30-Day Fills
Letrozole
Most Prescribed · 35 claims
View details
2 medications · 2024 Medicare Part D
Medicare Part D medications prescribed by MARY ELLEN MAHONEY M.D. in 2024, with prescription volumes, average cost per fill, and CA state comparisons
Medication Prescriptions (2024)Rx (2024) Avg Cost per FillCost / Fill Vs. Other CA PrescribersVs. CA Avg
Letrozole35$16.97▼ below CA avg▼ Less than typical

About Letrozole: This medication is used to treat certain types of breast cancer (such as hormone-receptor-positive breast cancer) in women after menopause. Show more ▾

Letrozole is also used to help prevent the cancer from returning. Some breast cancers are made to grow faster by a natural hormone called estrogen. Letrozole decreases the amount of estrogen the body makes and helps to slow or reverse the growth of these breast cancers. A triazole and benzonitrile derivative that is a selective non-steroidal aromatase inhibitor, similar to ANASTROZOLE. It is used in the treatment of metastatic or locally advanced breast cancer in postmenopausal women.

In 2024, this provider wrote 35 Medicare prescriptions for Letrozole, about 71% of the volume of the typical California prescriber of this medication (49.4). Medicare paid an average of $16.97 per fill, versus $22.86 statewide.

How often this provider prescribes it

This provider
35
CA average
49.4

This provider prescribes this medication less often than the average CA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$16.97
CA average
$22.86

This provider's average cost per fill is below the CA average for this medication.

88.5
30-Day Fills
standardized to 30-day supplies
2,655
Days of Medication
total across all patients in 2024
Tamoxifen Citrate28$24.19▼ below CA avg≈ Typical

About Tamoxifen Citrate: Tamoxifen is used to treat breast cancer. Show more ▾

It is also used to reduce the chances of breast cancer in high-risk patients. This medication can block the growth of breast cancer. It works by interfering with the effects of estrogen in the breast tissue. One of the SELECTIVE ESTROGEN RECEPTOR MODULATORS with tissue-specific activities. Tamoxifen acts as an anti-estrogen (inhibiting agent) in the mammary tissue, but as an estrogen (stimulating agent) in cholesterol metabolism, bone density, and cell proliferation in the ENDOMETRIUM.

In 2024, this provider wrote 28 Medicare prescriptions for Tamoxifen Citrate, about 79% of the volume of the typical California prescriber of this medication (35.4). Medicare paid an average of $24.19 per fill, versus $24.93 statewide.

How often this provider prescribes it

This provider
28
CA average
35.4

This provider's prescribing volume for this medication is in line with the average CA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$24.19
CA average
$24.93

This provider's average cost per fill is below the CA average for this medication.

82.5
30-Day Fills
standardized to 30-day supplies
2,475
Days of Medication
total across all patients in 2024
No medications match the current filters.
▲ More than typical≈ Typical▼ Less than typical= prescription volume vs the average CA prescriber of the same medication; volume reflects practice size as well as clinical preference.Green cost= below the CA average cost per fill.

About this data. The prescription history for MARY ELLEN MAHONEY M.D. is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2024, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Surgery prescribing approach at this Eureka, CA practice.

Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average among CA prescribers of the same medication and form, shown only when at least five prescribers contribute. Always confirm current medications and costs directly with the provider and your plan.

About the medication summaries. Drug use descriptions come from the CMS Medicare Part D Drug Spending Dashboard (2024), and substance definitions from Medical Subject Headings (MeSH) 2026, U.S. National Library of Medicine. They are summaries that do not contain all possible information about a medication and are not individual medical advice. Ask a health care professional about any medication and your specific health needs.